Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M669Revenue $M318Net Margin (%)8.1Z-Score3.4
Enterprise Value $M724EPS $0.8Operating Margin %15.6F-Score6
P/E(ttm))20.3Cash Flow Per Share $1.3Pre-tax Margin (%)14.2Higher ROA y-yN
Price/Book2.910-y EBITDA Growth Rate %0Quick Ratio1.1Cash flow > EarningsY
Price/Sales2.05-y EBITDA Growth Rate %10.4Current Ratio2.2Lower Leverage y-yY
Price/Cash Flow8.9y-y EBITDA Growth Rate %31.1ROA % (ttm)5.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)12.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M30.6ROI % (ttm)25.6Gross Margin Increase y-yY

Gurus Latest Trades with CBM

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CBMJoel Greenblatt 2013-03-31 Sold Out -0.09%$11.27 - $12.79
($11.93)
$ 21.8283%Sold Out0
CBMJoel Greenblatt 2012-12-31 Buy 0.09%$9.34 - $13.96
($11.38)
$ 21.8292%New holding, 142352 sh.142,352
CBMJoel Greenblatt 2012-09-30 Sold Out -0.02%$9.01 - $13.01
($11.05)
$ 21.8298%Sold Out0
CBMJoel Greenblatt 2012-06-30 Buy 0.02%$5.96 - $9.16
($7.07)
$ 21.82209%New holding, 30208 sh.30,208
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CBM is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CBM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Haskel William M.Senior Vice President 2014-08-07Sell28,100$22.5-3.02 view
KLOSK STEVEN MPresident & CEO 2014-08-07Sell1,200$22.52-3.11 view
SARGEN GREGORYEVP & CFO 2014-08-05Sell50,000$22.34-2.33 view
WINSCHEL JAMES F JRDirector 2014-08-05Sell600$22.28-2.06 view
WINSCHEL JAMES F JRDirector 2014-08-05Buy600$22.28-2.06 view
HENDRIX LEON J JRDirector 2014-02-28Sell23,000$20.098.61 view
HENDRIX LEON J JRDirector 2014-02-20Sell975$21.91-0.41 view
Magnini AldoManaging Director-Profarmaco 2014-02-20Sell6,000$22.1-1.27 view
SARGEN GREGORYEVP & CFO 2014-02-18Sell38,500$21.660.74 view
TOMBROS PETER GDirector 2014-02-13Sell1,350$20.874.55 view

Press Releases about CBM :

    Quarterly/Annual Reports about CBM:

    News about CBM:

    Articles On GuruFocus.com
    Cambrex Corp. Reports Operating Results (10-Q) Aug 04 2010 
    Cambrex Corp. Reports Operating Results (10-Q) May 05 2010 
    Does Cambrex Corporation Have Earnings Persistence? Apr 28 2010 
    Cambrex Corp. Reports Operating Results (10-Q) Nov 04 2009 


    More From Other Websites
    NYSE stocks posting largest percentage increases Aug 19 2014
    Celladon Corp. (CLDN) Jumps: Stock Adds 11.3% in Session Aug 19 2014
    Should Achillion Pharma (ACHN) Be In Your Portfolio Now? Aug 18 2014
    Five Prime Therapeutics (FPRX) Jumps: Stock Adds 10.3% in Session Aug 12 2014
    OncoMed Pharmaceuticals Slumps: OMED Plunges 10.2% in Session Aug 12 2014
    Zacks Rank #1 Additions for Monday Aug 11 2014
    CAMBREX CORP Financials Aug 08 2014
    Cambrex Corporation (CBM) in Focus: Stock Up 7.3% Aug 04 2014
    Cambrex Reports Second Quarter 2014 Financial Results Aug 02 2014
    Cambrex Corp Earnings Call scheduled for 8:30 am ET today Aug 01 2014
    CAMBREX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 01 2014
    Q2 2014 Cambrex Earnings Release - Before Market Open Aug 01 2014
    Cambrex Reports Second Quarter 2014 Financial Results Aug 01 2014
    Cambrex To Announce Second Quarter 2014 Financial Results On August 1, 2014 Jul 29 2014
    Cambrex Manufacturing Facility Completes Successful US FDA Pre-Approval Inspection Jul 12 2014
    Cambrex Manufacturing Facility Completes Successful US FDA Inspection Jul 12 2014
    NeoStem Appoints Steven M. Klosk to Board of Directors Jul 08 2014
    NeoStem Appoints Steven M. Klosk to Board of Directors Jul 08 2014
    CAMBREX CORP Files SEC form 8-K, Change in Directors or Principal Officers May 29 2014
    James F. Winschel Appointed to the Board of Directors of Cambrex Corporation May 29 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide